Ascendis Pharma A/S/ US04351P1012 /
2024-05-17 4:28:50 PM | Chg. -0.94 | Volume | Bid4:28:52 PM | Ask- | High | Low |
---|---|---|---|---|---|---|
121.96USD | -0.76% | 8,654 Turnover: 1.06 mill. |
121.88Bid Size: 100 | -Ask Size: - | 123.03 | 121.84 |
GlobeNewswire
05-14
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™...
GlobeNewswire
05-13
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire
05-13
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire
05-09
Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with...
GlobeNewswire
04-25
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2,...
GlobeNewswire
04-24
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment o...
GlobeNewswire
04-16
Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.
GlobeNewswire
03-04
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024
GlobeNewswire
01-31
Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7...
GlobeNewswire
01-31
Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for ...
GlobeNewswire
01-29
New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitm...
GlobeNewswire
01-09
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocr...
GlobeNewswire
01-08
Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S for Skytrofa (...
GlobeNewswire
2023-12-28
Ascendis Pharma to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-12-20
Significant Health and Quality of Life Improvements Achieved in Children with Achondroplasia Treated...
GlobeNewswire
2023-12-19
TransCon™ hGH (lonapegsomatropin) Achieved Statistically Superior Outcomes Compared to Placebo in Ph...
GlobeNewswire
2023-12-11
FDA Accepts for Review Resubmitted NDA for TransCon PTH (Palopegteriparatide) in Adult Patients with...
GlobeNewswire
2023-11-29
Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan